Articles
CODING Q&A
Diabetes Coding for ICD-10-CM
Emerging Treatment for X-linked Retinoschisis
A rare inherited retinal disease with no current treatment meets ocular gene therapy.
FOCUS ON...
Optical Coherence Tomography Angiography Revolutionizes Ocular Flow Assessment
By Karen Appold, contributing writer
Hydroxychloroquine Maculopathy: An Update on Screening and Diagnosis
A brief guide for imaging
Management of Macular Edema in RVO
Several modalities of treatment are available, but knowing the right combination is helpful.
Managing Pseudophakic Cystoid Macular Edema
Advancements have been made with current imaging.
Radiotherapy for Wet AMD
Real-world results of stereotactic radiotherapy have begun to emerge.
SUBSPECIALTY NEWS
By Jerry Helzner, contributing editor
Sustained Anti-VEGF Therapy for Neovascular AMD
Complications occur over time, but most are minor.
UPFRONT
The Genetic Lottery
Finding an Effective Sequential Approach to DME Therapy
Case #5: Fluctuating response to anti-VEGF monotherapy stabilizes and improves with addition of dexamethasone intravitreal implant.
By Michael A. Singer, MD
Identifying and Managing an Overwhelming Inflammatory Component
Case #4: Bilateral severe peripheral ischemia with extensive leakage owing to diabetic macular edema and neovascularization.
By Daniel F. Kiernan, MD, FACS
Managing the Complex Pathology of Diabetic Macular Edema
Case #1: Severe bilateral nonproliferative diabetic retinopathy and clinically significant DME.
By Bozho Todorich, MD, PhD
The Challenge of Maintaining Visual and Anatomic Stability for a Lifetime
Case #2: Persistent and unstable bilateral diabetic macular edema complicated by poor attendance at clinic appointments.
By Seenu M. Hariprasad, MD
The Importance of Quickly Identifying a Suboptimal Response
Case #3: Chronic, persistent diabetic macular edema treated with concurrent anti-VEGF and dexamethasone intravitreal implant.
By Michael Javaheri, MD